| Form type | Sec Links | Description | Filing date | Reporting date |
|---|---|---|---|---|
| SC 13G | Report | Oct 24, 2024 | ||
| SC 13G/A | Report | SC 13G/A | Feb 14, 2024 | |
| SC 13G/A | Report | NEW ENTERPRISE ASSOCIATES 15, L.P. / INOZYME PHARMA -- 13G/A(#2E) | Feb 14, 2024 | |
| SC 13G/A | Report | SC 13G/A | Feb 14, 2024 | |
| SC 13G/A | Report | Feb 14, 2024 | ||
| SC 13G | Report | Feb 14, 2024 | ||
| SC 13G | Report | SC 13G | Feb 14, 2024 | |
| SC 13G/A | Report | Feb 14, 2024 | ||
| SC 13G/A | Report | INOZYME PHARMA, INC. | Feb 7, 2024 | |
| SC 13G/A | Report | SC 13G/A | Feb 5, 2024 | |
| SC 13G/A | Report | Jan 16, 2024 | ||
| SC 13G | Report | May 31, 2023 | ||
| SC 13G | Report | SC 13G | Mar 7, 2023 | |
| SC 13G/A | Report | SC 13G/A | Feb 14, 2023 | |
| SC 13G | Report | SC 13G | Feb 14, 2023 | |
| SC 13G/A | Report | Feb 14, 2023 | ||
| SC 13G/A | Report | Feb 14, 2023 | ||
| SC 13G | Report | CHI ADVISORS LLC | Feb 13, 2023 | |
| SC 13G/A | Report | Feb 10, 2023 | ||
| SC 13G/A | Report | INOZYME PHARMA, INC. | Feb 9, 2023 | |
| SC 13G | Report | SC 13G | Apr 29, 2022 | |
| SC 13G | Report | Apr 25, 2022 | ||
| SC 13G | Report | Apr 18, 2022 | ||
| SC 13G/A | Report | SC 13G/A | Feb 14, 2022 | |
| SC 13G/A | Report | Feb 11, 2022 | ||
| SC 13G/A | Report | INOZYME PHARMA, INC. | Feb 10, 2022 | |
| SC 13G/A | Report | NEW ENTERPRISE ASSOCIATES 15, L.P. / INOZYME PHARMA -- 13GA(#1) | Feb 7, 2022 | |
| SC 13G/A | Report | SCHEDULE 13G/A | Nov 15, 2021 | |
| SC 13G | Report | INOZYME PHARMA, INC. | May 10, 2021 | |
| SC 13G | Report | SCHEDULE 13G | Feb 16, 2021 | |
| SC 13G | Report | NEW ENTERPRISE ASSOCIATES 15, L.P. / INOZYME PHARMA -- 13G | Feb 12, 2021 | |
| SC 13G | Report | SC 13G | Feb 9, 2021 | |
| SC 13G | Report | Aug 6, 2020 |